NCT00767312
Analysis of HIV-1 Replication During Antiretroviral Therapy
Enrolling by Invitation
Not specifiedAges 18–99ObservationalNational Institute of Allergy and Infectious Diseases (NIAID)Government-funded
~70 participants
Updated 2026-07-23 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
We plan to investigate the relationship of HIV-1 viral RNA levels and genetic variation in patients on antiretroviral therapy over prolonged periods.
Measured over every 6 months
Conditions
Where it's being run
1 sites across 1 statesMaryland1
Study leadership
- Frank Maldarelli, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Allergy and Infectious Diseases (NIAID)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age greater than or equal to 18 years.
HIV infection with documented reactive ELISA and positive western blot.
Prior enrollment in 00-I-0110, 97-I-0082 OR patients with long term evaluation at NIH for whom additional sampling will be useful for protocol objectives, including:
Available stored specimens from pretherapy period.
Ongoing suppression of viremia with bDNA less than 50 copies/mL, OR
Suppression of viremia to less than 50 copies/mL followed by rebound viremia during therapy.
Patients must have a private physician for routine medical care.
What this trial measures
- We plan to investigate the relationship of HIV-1 viral RNA levels and genetic variation in patients on antiretroviral therapy over prolonged periods.every 6 months
HIV-1 viral RNA